Boston, MA 05/05/2014 (wallstreetpr) – Qlik Technologies Inc (NASDAQ:QLIK) misses the earning expectations but is ready with the next version of its software. The company is also successful in the field of medical analyses and cancer detection.
Click Technologies misses expectations
Qlik Technologies reported its 1Q2014 revenues which missed the market’s expectations. The revenue for 1Q2014 was $111 million. It means a net loss of 12% per share. According to the expectations, the company needed to make $113 million, which meant 13% loss per share.
New version of software
Qlik Technologies Inc (NASDAQ:QLIK) is launching a new version of its software named as “Qlikview.Next.” It’s on schedule for the launch of this new version.
Revenues
Estimates for the current quarter see the revenue at a range of $124 million to $128 million, which will mean a net loss of 2 cents to 4 cents per share. For the full financial year FY 2014, Qlik Technologies Inc (NASDAQ:QLIK) estimates its revenue in the range of $545 million to $555 million. The estimation expects a profit in the range of 23 cents to 27 cents.
Improved breast Cancer detection with QlikView
German screening centres are able to improve their breast Cancer detection with QlikView. Using the software made by Qlik, the leading company in Business Intelligence (BI), these centres are able to evaluate their data better. The software helps them to offer faster and easier data analysis for detection of breast cancer in patients. The “MaSc View” application, which is powered by QlikView Business Discovery, is capable of producing better results. It can take data from different sources and consolidate them for different types of analysis and measurements. It offers timely evaluation besides improving the overall process management.
With the success in few screening centres, more and more demand for the technology and platform will be in the near future.
